EDMONTON, AB, Nov. 22, 2021 /CNW/ - Aurora Cannabis Inc.
(NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future
of cannabinoids worldwide, today announced a renewed sponsorship of
Cannabis Amnesty in support of their advocacy work, calling for
blanket pardons to all individuals for the offence of simple
possession of cannabis. The sponsorship will support Cannabis
Amnesty's campaign to right these historical wrongs –
especially the impact on racialized communities.
Over half a million Canadians still have criminal records for
simply possessing cannabis; creating barriers to meaningful work,
volunteering, and travel.
"As a proudly Canadian company, Aurora values our roots in
advocating for cannabis record pardons with Cannabis Amnesty," says
Miguel Martin, CEO. "We have a
responsibility to those communities who have been
disproportionately impacted. Canadians, or anyone for that matter,
shouldn't be burdened with a criminal record for a minor,
non-harmful act that is no longer a crime."
The $50,000 contribution from
Aurora will enable Cannabis Amnesty to enhance their operations,
facilitating their ability to directly engage with and support
communities harmed by cannabis prohibition. A portion of
the funds will go toward the hiring of Cannabis Amnesty's
first full-time staff member, in collaboration with TOQi
Technologies Ltd., to lead the next phase of cannabis advocacy.
This includes calling for pardons and cannabis record expungement
with a focus on the disproportionate criminal records still held by
racialized communities in Canada
and working in the community to provide pardon resources directly
to individuals.
"Aurora's Cannabis Amnesty sponsorship demonstrates leadership
within the cannabis industry, taking a step forward to address the
social inequities of cannabis prohibition," says Annamaria Enenajor, Founder of Cannabis Amnesty.
"Cannabis Amnesty looks forward to working with Aurora to help
influence policy for the better, and continue the call for cannabis
record expungement here in Canada.
About Cannabis Amnesty:
Cannabis Amnesty is an independent, not-for-profit advocacy
group focused on righting the historical wrongs caused by decades
of cannabis prohibition, particularly its impact on racialized
communities. It was founded in April
2018, in response to the absence of federal legislation
addressing the stigma of previous convictions for offences that
would no longer be illegal under the Cannabis Act. Since then, they
have campaigned for the government to enact legislation to delete
criminal records relating to the simple possession of cannabis,
launched public education campaign to fight the stigma associated
with cannabis convictions and worked on criminal justice reform to
make sure that the legal structures that allowed marginalized
communities to be overrepresented in cannabis prosecutions are
dismantled. Visit www.cannabisamnesty.ca for more information.
About Aurora:
Aurora is a global leader in the cannabis industry, serving
both the medical and consumer markets. Headquartered in
Edmonton, Alberta, Aurora is a
pioneer in global cannabis dedicated to helping people improve
their lives. The Company's brand portfolio includes
Aurora, Aurora Drift, San Rafael '71, Daily
Special, MedReleaf, CanniMed, Whistler, Reliva and KG7
CBD. Driven by science and innovation, and with a focus on
high-quality cannabis products, Aurora's brands continue to break
through as industry leaders in the medical, performance,
wellness and adult recreational markets
wherever they are launched. Learn more
at www.auroramj.com and follow us
on Twitter and LinkedIn.
Aurora's common shares trade on the TSX
and NASDAQ under the symbol "ACB" and is a constituent of
the S&P/TSX Composite
Index.
Forward-looking Information
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. Forward-looking statements made in
this news release include, but are not limited to, statements
regarding the Company's renewed sponsorship of, and financial
contribution to, Cannabis Amnesty and the anticipated associated
impact on Cannabis Amnesty's operations and advocacy work.
These forward-looking statements are only predictions. Forward
looking information or statements contained in this news
release have been developed based on assumptions
management considers to be reasonable. Material factors
or assumptions involved in developing forward-looking statements
include, without limitation, publicly available information from
governmental sources as well as from market research and industry
analysis and on assumptions based on data and knowledge of this
industry which the Company believes to be reasonable.
Forward-looking statements are subject to a variety of risks,
uncertainties and other factors that management believes to be
relevant and reasonable in the circumstances could cause actual
events, results, level of activity, performance, prospects,
opportunities or achievements to differ materially from those
projected in the forward-looking statements. These risks
include, but are not limited to, the ability to retain key
personnel, the ability to continue investing in infrastructure to
support growth, the ability to obtain financing on acceptable
terms, the continued quality of our products, customer experience
and retention, the development of third party government and
non-government consumer sales channels, management's
estimates of consumer demand in Canada and in jurisdictions where the Company
exports, expectations of future results and expenses, the risk
of successful integration of acquired business and operations,
management's estimation that SG&A will grow only in proportion
of revenue growth, the ability to expand and maintain distribution
capabilities, the impact of competition, the general impact of
financial market conditions, the yield from cannabis growing
operations, product demand, changes in prices of required
commodities, competition, and the possibility for changes in laws,
rules, and regulations in the industry, epidemics, pandemics or
other public health crises, including the current outbreak of
COVID-19, and other risks, uncertainties and factors set out
under the heading "Risk Factors" in the Company's annual
information form dated September 27,
2021 (the "AIF") and filed with Canadian securities
regulators available on the Company's issuer profile on SEDAR
at www.sedar.com and filed with and available on the
SEC's website at www.sec.gov. The Company cautions that
the list of risks, uncertainties and other factors described in the
AIF is not exhaustive and other factors could also adversely affect
its results. Readers are urged to consider the risks, uncertainties
and assumptions carefully in evaluating the forward-looking
statements and are cautioned not to place undue reliance on such
information. The Company is under no obligation, and expressly
disclaims any intention or obligation, to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, except as expressly required by
applicable securities law.
SOURCE Aurora Cannabis Inc.